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Atypical teratoid/rhabdoid tumors are rare and highly malignant central nervous system tumors. They have no
specific radiological features and often present several histological components that make a problem in differential
diagnosis with medulloblastoma and primitive neuroectodermal tumors.
We present the case of a newborn girl complained of a gradual proptosis of the left eye secondary to an expansive
lesional process of the optic nerve. The location at the optic nerve, reported only twice in the literature, and an
exclusive rhabdoid appearance on biopsy added additional differential diagnosis problems.
The proptosis worsened and the infant died few days after two cycles of chemotherapy.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
2037718783145212.
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World Health Organization (WHO) defines atypical
teratoid/rhabdoid tumour (AT/RT) as a highly malignant
central nervous system (CNS) tumour predominantly
manifesting in young children, typically containing
rhabdoid cells, often with primitive neuroectodermal
cells and with divergent differentiation along epithelial,
mesenchymal, neuronal or glial lines; associated with
inactivation of the integrase interactor (INI)1/hSNF5
gene in virtually all cases [1]. AT/RTs have non-specific
clinical and radiological features, often present several
components at histology and are commonly infratentorial,
making a problem in differential diagnosis with medullo-
blastoma, primitive neuroectodermal tumors (PNET) and
germ cells tumors. In our case, the location at the optic
nerve, reported only twice in the literature, added an
additional differential diagnosis problem with optic nerve* Correspondence: ysf.mahdi@gmail.com
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biopsy referred us first to rhabdomyosarcoma.
Case presentation
Clinical history
A newborn girl, without perinatal history, presented at
birth a gradual increase of the left eye volume. At
day 20 of life, parents decided to consult a doctor. Physical
examination showed proptosis of the left eye.
Radiologic and histopathologic findings
The ultrasound revealed 2 cm hypoechoic formation
occupied the posterior pole of the orbit without Doppler
vascularity, well limited by printing capsule at the
bottom and outside of the optic nerve. The globe was
normal. Orbital magnetic resonance imaging (MRI)
revealed an expansive fusiform lesional process in intraco-
nal space encompassing the optic nerve, measured 25/19/
17 mm (Figure 1). This aspect evoked optic nerve glioma.
Bilateral cortical atrophy in frontotemporal cortex was
also observed. Thoraco-abdominal computed tomography
(CT) showed right renal malrotation without tumor.
As a result, a biopsy was performed. Microscopically, weThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 MRI aspect in admission. Axial T2-weighted MR image shows hyperintense signal and enlargement of the left optic nerve (arrow).
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neoplastic cells. Their cytoplasm was eosinophilic and
sometimes contained eosinophilic globular inclusions.
The nucleus was irregular, with vesicular chromatin and
several mitotic figures estimated at 8 mitoses per 10 high
power fields (Figure 2A). The immunohistochemical
study showed reactivity for epithelial membrane anti-
gen (EMA) (Figure 2B), vimentin (Figure 2C), S100
protein (Figure 2D), pancytokeratin (Figure 2E) and
glial fibrillary acidic protein (GFAP). The tumor was
immunonegative for desmin, myogenin, INI1, chromo-
granin, synaptophysin, CD34, CD99 and CK5/6. The
diagnosis was atypical teratoid/rhabdoid tumor. TheFigure 2 Histological aspect and immunohistochemical profile of the lesion.
globular inclusions (arrows). The nucleus is irregular with vesicular chromatin
positive for EMA (B), vimentin (C), S100 protein (D) and pancytokeratin (E).patient received cyclophosphamide/vincristine/ifosfamide/
actinomycine-based chemotherapy. Evolution was marked
by a worsening of proptosis after two cycles of chemother-
apy. A new MRI redone objectified a huge heterogeneous
left orbito-cerebral mass contained calcifications, enhanced
intensely after injection of contrast agent, measured
110 and 100 mm (Figure 3). It showed a bone lysis of
the orbital frame, invasion of the left cavernous sinus,
extension and infiltration of the temporal lobe and
supra sellar region. Lesion resulted of mass effect on
the lateral ventricles causing triventricular dilatation.
The infant died few days after second course of
chemotherapy.(A). The cytoplasm of neoplastic cells contains sometimes eosinophilic
and several mitotic figures (arrowhead) (H & E × 400). The tumor cells are
Figure 3 Evolution after 2 courses of chemotherapy. Axial T2-weighted MR image redone objectives a huge heterogeneous orbito-cerebral mass,
enhanced intensely after injection of contrast agent and associated to triventricular dilatation.
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Malignant rhabdoid tumors were originally described in
kidney then at other sites especially soft tissue [2-9]. In
1985, Briner et al. reported the first case of primary
cerebral rhabdoid tumor [10]. The term AT/RT was pro-
posed for this entity by Rorke et al. because of the combin-
ation of rhabdoid, primitive neuroepithelial, epithelial and
mesenchymal components [11]. AT/RTs represent 1–2% of
paediatric brain tumours [1]. They usually occur in
children under the age of 3 years, and rarely affect those
older than 6 years, with a median age of 2 years [1].
There is a male predominance ranging from 1.6–2:1 [1].
Presenting symptoms are non-specific, represented by
lethargy, vomiting or failure to thrive in infants, headache
and hemiplegia in children older than three years [1].
AT/RTs are most often infratentorial [12,13], located
in the cerebellar hemispheres, cerebellopontine angle orbrain stem [1,12]. Supratentorial tumors are commonly
located in the cerebral hemispheres, and less frequently in
the ventricular system, suprasellar region or pineal gland
[1]. They rarely arise in the spinal cord [1,13]. Seeding of
AT/RTs via the cerebrospinal fluid pathways is found in
more than 20% of the patients at presentation [1].
AT/RT of the optic nerve, as in our case, is exceptional
and only two cases were reported in the literature. In
2006, Allen et al. described a case of an AT/RT of the
optic nerve secondarily arising in a ganglioglioma [14].
Verma et al. reported in 2008 a case of primary AT/RT in
optic nerve in 2-years-old boy [15]. In addition, Fujita et al.
reported in 2005 a case of multicentric AT/RTs occurring
in the eye and fourth ventricle but without involvement of
optic nerve [16].
CT reveals a hyperdense solid component with moderate
to marked enhancement with contrast medium [17]. MRI
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evaluation of the optic pathway [18]. It often shows isoin-
tense or hypointense signal on T1 and T2 weighted images
[17]. There is a tendency for calcification, hemorrhage,
necrosis and perifocal edema [17]. At the optic nerve, these
radiological features are similar to optic nerve gliomas
(ONG), accounting for 66% of all primary tumors of the
optic nerve [18]. However, ONG are hyperintense to
cerebral cortex on the T2-weighted images [18]. In
addition, the peak age of occurrence ranges from 2 to
8 years old and typically follows an indolent course
[18]. In another sites, the imaging findings are similar
to those seen in patients with medulloblastoma or
PNET. Compared with medulloblatomas, AT/RTs have an
increased rate of cerebellopontine angle involvement and
intratumoral hemorrhage [19].
Macroscopically, AT/RTs tend to be soft, pinkish-red
and bulky, and typically contain necrotic foci and may
be haemorrhagic [1].
Histologically, the most striking feature are nests or
sheets of cells with classic rhabdoid features: abundant
cytoplasm contains paranuclear eosinophilic globular
inclusion, eccentrically placed nuclei with a vesicular
chromatin and a prominent nucleoli [1,12]. By electron
microscopy the cytoplasmic inclusions correspond to
bundles of intermediate filaments forming tight whorls
[12]. The rhabdoid cells can have less striking nuclear
atypia and large amounts of pale eosinophilic cytoplasm
[1]. However, cases in which the cells are the exclusive
or predominant are rare, and most tumours contain
variable components with primitive neuroectodermal,
mesenchymal and epithelial features [1]. Primitive neu-
roectodermal component is encountered in two thirds of
cases and have the appearance of other small blue cell
tumors of childhood [1,12]. Mesenchymal and epithelial
differentiations are less common and appear as areas
with spindle cell features in the first one and as papillary
structures, adenomatous areas or poorly differentiated
ribbons and cords in the second one [1]. In immunohis-
tochemical study, AT/RTs display a polyphenotypic
immunophenotype [1,12]. However, the rhabdoid cells
characteristically demonstrate consistent expression of
epithelial membrane antigen and vimentin [1]. Expression
of smooth muscle actin, GFAP, neurofilament protein,
synaptophysin and keratins are also commonly observed
[1,12]. Loss of nuclear expression of INI1 in tumour cells
has been shown to be a sensitive and specific marker for
AT/RTs [1,20]. It may have particular utility in case of
tumors with indeterminate histologic features or atypical
immunophenotypic profiles [20].
In our case, we dealt with a biopsy showed only rhabdoid
cells. The problem of differential diagnosis arose with
rhabdomyosarcoma. The negativity of desmin at first
then the negativity of the INI 1 allowed us to rectify thediagnosis. In other locations, the differential diagnosis
includes medulloblastomas, PNET and germ cells tumors.
ATRT shares some morphological features with those
entities, but the presence of rhabdoid cells as well as
immunohistochemical study gave the correct diagnosis.
Deletions and mutations of the hSNF5/INI1/SMARCB1
locus at 22q11.2 were demonstrated in AT/RTs as well as
in rhabdoid tumors of the kidney and extra-renal sites
[21,22]. It suggested that INI1 is a tumor suppressor gene
involved in rhabdoid tumors [22]. AT/RTs can occur
sporadically or as part of rhabdoid tumor predisposition
syndrome [1].
For treatment, there are no definitive guidelines for
AT/RTs because of their rarity. However, it based on
surgical resection, chemotherapy and radiotherapy.
Surgical resection must be as radical as possible. Indeed,
patients undergoing gross total resection have a better
survival compared to the patients with incomplete resec-
tion [13,23]. Radiotherapy is crucial in the treatment and
can be focal or craniospinal [23]. It recommended to initi-
ate it immediately postoperatively and before systemic
chemotherapy in pediatric patients older than 3 years [23].
For chemotherapy, several drugs are used in various
regimens including: vincristine, carboplatin, cisplatinum,
cyclophosphamide, etoposide, ifosfamide, methotrexate,
lomustine and temozolomide [13]. High dose chemother-
apy regimens are associated with a significant survival
benefit [13]. However, the used of intrathecal chemotherapy
is not associated with a significant prognostic value [13].
AT/RTs correspond to WHO grade IV, having a poor
prognosis [1]. The mean survival is 6–11 months [12].
Conclusion
In summary, AT/RTs are very aggressive CNS embryonal
tumors that make several problems in differential diagnosis.
In our case, the location and the histological aspect posed
additional diagnostic difficulties. An accurate diagnosis is
imperative because AT/RTs have worse prognosis. At that
context, pathological analysis is critical.
Consent
Written informed consent was obtained from the parents
of the patient for publication of this Case Report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
Abbreviations
WHO: World Health Organization; AT/RT: Atypical teratoid/rhabdoid tumour;
CNS: Central nervous system; INI: Integrase interactor; PNET: Primitive
neuroectodermal tumors; MRI: Magnetic resonance imaging; CT: Computed
tomography; EMA: Epithelial membrane antigen; GFAP: Glial fibrillary acidic
protein; ONG: Optic nerve gliomas.
Competing interests
The authors declare that they have no competing interests.
Mahdi et al. Diagnostic Pathology  (2015) 10:47 Page 5 of 5Authors’ contributions
YM analyzed and interpreted the patient data, drafted the manuscript and
made the figures. NC performed the histological examination, proposed the
study, supervised YM and revised the manuscript. AA, HE and MZB have
made substantial contributions to analysis and interpretation of patient data.
JK, IE, MM, AK and RD provided valuable insight during manuscript
preparation. All authors read and approved the final manuscript.
Acknowledgements
Acknowledgements to Dr Karima Mokhtari, Department of Neuropathology,
Raymond Escourolle, Hôpital Pitié-Salpêtrière, Paris, France, for her opinion
and INI1 immunohistochemistry.
Acknowledgements to Dounia Lourirhi for language corrections.
Author details
1Department of Pathology, Specialities Hospital, Ibn Sina University Hospital,
Rabat, Morocco. 2Faculty of Medicine and Pharmacy, Mohammed V Souissi
University, Rabat, Morocco. 3Department of Ophtamology, Specialities
Hospital, Ibn Sina University Hospital, Rabat, Morocco. 4Pediatric Hematology
and Oncology Center, Ibn Sina University Hospital, Rabat, Morocco.
Received: 7 October 2014 Accepted: 22 April 2015
References
1. Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/rhabdoid tumor.
World Health Organization Classification of tumors of the central nervous
system. Lyon: IARC Press; 2007. p. 147–9.
2. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors:
results from the First National Wilms’ Tumor Study. Cancer. 1978;41(5):1937–48.
3. Hass JE, Palmer NF, Weinberg AG, Beckwith JB. Ultrastructure of malignant
rhabdoid tumor of the kidney. A distinctive renal tumor of children.
Hum Pathol. 1981;12(7):646–57.
4. Beckwith JB. Wilms’ tumor and other renal tumors of childhood: A selective
review from the National Wilms’ Tumor Study Pathology Center.
Hum Pathol. 1983;14:481–92.
5. Palmer NF, Sutow W. Clinical aspects of the rhabdoid tumor of the kidney:
a report of the National Wilms’ Tumor Study Group. Med Pediatr Oncol.
1983;11(4):242–5.
6. Weeks DA, Beckwith JB, Mierau GW, Luckey DW. Rhabdoid tumor of kidney.
A report of 111 cases from the National Wilms’ Tumor Study Pathology
Center. Am J Surg Pathol. 1989;13(6):439–58.
7. Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M. Malignant soft tissue
neoplasms with the histologic features of renal rhabdoid tumors:
an ultrastructural and immunohistochemical study. Hum Pathol.
1985;16:1235–42.
8. Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M. The existence of rhabdoid
cells in specified soft tissue sarcomas. Histopathological, ultrastructural and
immunohistochemical evidence. Virchows Arch A Pathol Anat Histopathol.
1987;411(6):509–14.
9. Fanburg-Smith JC, Hengge M, Hengge UR, Smith Jr JS, Miettinen M.
Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and
immunohistochemical study of 18 cases. Ann Diagn Pathol.
1998;2(6):351–62.
10. Briner J, Bannwart F, Kleihues P, Odermatt B, Janzer R, Willi U, et al.
Malignant small cell tumor of the brain with intermediate filaments. A case
of primary cerebral rhabdoid tumor. Pediatr Pathol. 1985;3:117–78.
11. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical
teratoid/rhabdoid tumors of infancy and childhood: Definition of an
entity. J Neurosurg. 1996;85:56–65.
12. Isaacs H. Perinatal Brain Tumors: A Review of 250 Cases. Pediatr Neurol.
2002;27:333–42.
13. Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, et al.
Central nervous system atypical teratoid rhabdoid tumours: The Canadian
Paediatric Brain Tumour Consortium experience. Eur J Cancer.
2012;48:353–9.
14. Allen JC, Judkins AR, Rosenblum MK, Biegel JA. Atypical teratoid/rhabdoid
tumor evolving from an optic pathway ganglioglioma: case study.
Neuro Oncol. 2006;8:79–82.
15. Verma A, Morriss C. Atypical teratoid/rhabdoid tumor of the optic nerve.
Pediatr Radiol. 2008;38:1117–21.16. Fujita M, Sato M, Nakamura M, Kudo K, Nagasaka T, Mizuno M, et al.
Multicentric atypical teratoid/rhabdoid tumors occurring in the eye and fourth
ventricle of an infant: case report. J Neurosurg. 2005;102(3 Suppl):299–302.
17. Parmar H, Hawkins C, Bouffet E, Rutka J, Shroff M. Imaging findings in
primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol.
2006;36:126–32.
18. Hollander MD, FitzPatrick M, O’Connor SG, Flanders AE, Tartaglino LM.
Optic gliomas. Radiol Clin North Am. 1999;37(1):59–71. ix.
19. Koral K, Gargan L, Bowers DC, Gimi B, Timmons CF, Weprin B, et al. Imaging
characteristics of atypical teratoid–rhabdoid tumor in children compared
with medulloblastoma. AJR Am J Roentgenol. 2008;190:809–14.
20. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA. Immunohistochemical
analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol.
2004;28(5):644–50.
21. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P,
Handgretinger R, et al. Truncating mutations of hSNF5/INI1 in aggressive
paediatric cancer. Nature. 1998;394:203–6.
22. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B.
Germ-Line and Acquired Mutations of INI1in Atypical Teratoid and Rhabdoid
Tumors. Cancer Res. 1999;59:74–9.
23. Chen YW, Wong TT, Ho DM, Huang PI, Chang KP, Shiau CY, et al. Impact of
radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor
(single institute experience). Int J Radiat Oncol Biol Phys. 2006;64(4):1038–43.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
